AMRN vs JAZZ: Side-by-Side Comparison
Compare Amarin Corp (AMRN) and Jazz Pharmaceuticals plc (JAZZ) side by side: market cap USD 343.26M vs USD 15.28B. Financials, growth and model signals on Bullrun.
| Metric | AMRN | JAZZ |
|---|---|---|
| Company | Amarin Corp | Jazz Pharmaceuticals plc |
| Country / Exchange | Ireland · NASDAQ | Ireland · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers-General | Biotechnology |
| Market cap | USD 343.26M | USD 15.28B |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (FY2025) | USD 213.65M | USD 4.27B |
| Revenue growth YoY | -6.5% | +4.9% |
| Net income | USD -38.80M | USD -356.15M |
| Gross margin | 56.6% | — |
| Diluted EPS | -0.09 | -5.84 |